(Q47288193)

English

Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

author name string

Koichi Azuma

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Shigeki Shichijo

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Hiroki Shomura

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Satoko Matsueda

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Teruhiko Fujii

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Kyogo Itoh

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

86

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

19-29

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

https://scigraph.springernature.com/pub.10.1023/b:brea.0000032920.95410.63

0 references

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

IgG reactive to CTL‐directed epitopes of self‐antigens is either lacking or unbalanced in atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000032920.95410.63

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/B:BREA.0000032920.95410.63

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15218358

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47288193&oldid=2150536331"